Fig. 2
Wild type tubgcp2 mRNA pre-empts microcephaly in tubgcp2-depleted morphants at 3 dpf. (a) Percent of morphant larvae obtained with microcephaly when treated with tubgcp2 translation-inhibiting or splicing-inhibiting MO (see Supplementary Table S1 for experimental numbers and statistics). (b) Microcephaly index = head width/body length ratio = (c)/(d) for tubgcp2-depleted and tubgcp2 mRNA-rescued morphants. (c) Head width; (d) body length. Statistical multiple comparisons completed using one-way ANOVA; * p ? 0.05, ** p ? 0.01, *** p ? 0.001, **** p ? 0.0001. This includes ?idák?s correction for multiple comparisons.